MSc in Experimental and Translational Therapeutics at University of Oxford

Entry requirements

Entry for 2027-28. A first-class or strong upper second-class UK undergraduate degree with honours in a biological or medical science subject, including pharmacy and nursing, or equivalent demonstrable understanding and competence through training; professional experience may substitute for a relevant degree (US GPA normally 3.6/4.0). Applicants should have practical research and/or development experience, usually in a medical science-based company or research facility, a good working knowledge of email, internet, word processing and Windows applications, and evidence of interest in experimental therapeutics and translational medicine, motivation and a clear understanding of the course benefits. Three references and supporting documents. No GRE or GMAT. English language (higher level, if first language is not English): IELTS Academic 7.5 overall with at least 7.0 in each component; TOEFL iBT 110 with minimum Listening 22, Reading 24, Speaking 25, Writing 24; C1 Advanced 191 overall and 185 per component; C2 Proficiency 191 overall and 185 per component; Oxford Test of English Advanced 165 overall and 155 per component. Test must have been taken no more than two years before course start. Application deadline: 12:00 midday UK time on 27 January 2027 (final deadline for Oxford scholarships; expected final deadline 2 March 2027).